BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 14683458)

  • 1. Stearoyl-CoA desaturase-1 and the metabolic syndrome.
    Cohen P; Ntambi JM; Friedman JM
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):271-80. PubMed ID: 14683458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leptin and the control of metabolism: role for stearoyl-CoA desaturase-1 (SCD-1).
    Cohen P; Friedman JM
    J Nutr; 2004 Sep; 134(9):2455S-2463S. PubMed ID: 15333742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for stearoyl-CoA desaturase-1 in leptin-mediated weight loss.
    Cohen P; Miyazaki M; Socci ND; Hagge-Greenberg A; Liedtke W; Soukas AA; Sharma R; Hudgins LC; Ntambi JM; Friedman JM
    Science; 2002 Jul; 297(5579):240-3. PubMed ID: 12114623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stearoyl-CoA desaturase as a new drug target for obesity treatment.
    Dobrzyn A; Ntambi JM
    Obes Rev; 2005 May; 6(2):169-74. PubMed ID: 15836467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
    Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD
    Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melanin-concentrating hormone is a critical mediator of the leptin-deficient phenotype.
    Segal-Lieberman G; Bradley RL; Kokkotou E; Carlson M; Trombly DJ; Wang X; Bates S; Myers MG; Flier JS; Maratos-Flier E
    Proc Natl Acad Sci U S A; 2003 Aug; 100(17):10085-90. PubMed ID: 12897241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of stearoyl-CoA desaturase in body weight regulation.
    Dobrzyn A; Ntambi JM
    Trends Cardiovasc Med; 2004 Feb; 14(2):77-81. PubMed ID: 15030794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of stearoyl-CoA desaturase 1 rescues cardiac function in obese leptin-deficient mice.
    Dobrzyn P; Dobrzyn A; Miyazaki M; Ntambi JM
    J Lipid Res; 2010 Aug; 51(8):2202-10. PubMed ID: 20363835
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of murine SCD4, a novel heart-specific stearoyl-CoA desaturase isoform regulated by leptin and dietary factors.
    Miyazaki M; Jacobson MJ; Man WC; Cohen P; Asilmaz E; Friedman JM; Ntambi JM
    J Biol Chem; 2003 Sep; 278(36):33904-11. PubMed ID: 12815040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stearoyl-CoA desaturase-1 deficiency attenuates obesity and insulin resistance in leptin-resistant obese mice.
    Miyazaki M; Sampath H; Liu X; Flowers MT; Chu K; Dobrzyn A; Ntambi JM
    Biochem Biophys Res Commun; 2009 Mar; 380(4):818-22. PubMed ID: 19338759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic reprogramming of the heart through stearoyl-CoA desaturase.
    Dobrzyn P; Bednarski T; Dobrzyn A
    Prog Lipid Res; 2015 Jan; 57():1-12. PubMed ID: 25482956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
    Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR
    Diabetes; 2006 Jul; 55(7):2032-41. PubMed ID: 16804073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition.
    Xu H; Wilcox D; Nguyen P; Voorbach M; Smith H; Brodjian S; Suhar T; Reilly RM; Jacobson PB; Collins CA; Landschulz K; Surowy TK
    Front Biosci; 2007 May; 12():3781-94. PubMed ID: 17485339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of hepatic stearoyl-CoA desaturase-1 expression by fucoxanthin via leptin signaling in diabetic/obese KK-A(y) mice.
    Beppu F; Hosokawa M; Yim MJ; Shinoda T; Miyashita K
    Lipids; 2013 May; 48(5):449-55. PubMed ID: 23516000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered hepatic lipid metabolism contributes to nonalcoholic fatty liver disease in leptin-deficient Ob/Ob mice.
    Perfield JW; Ortinau LC; Pickering RT; Ruebel ML; Meers GM; Rector RS
    J Obes; 2013; 2013():296537. PubMed ID: 23401753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and physiological function of stearoyl-CoA desaturase.
    Paton CM; Ntambi JM
    Am J Physiol Endocrinol Metab; 2009 Jul; 297(1):E28-37. PubMed ID: 19066317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver.
    Dobrzyn P; Dobrzyn A; Miyazaki M; Cohen P; Asilmaz E; Hardie DG; Friedman JM; Ntambi JM
    Proc Natl Acad Sci U S A; 2004 Apr; 101(17):6409-14. PubMed ID: 15096593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The regulation of hepatic stearoyl-coenzyme A desaturase in obese-hyperglycaemic (ob/ob) mice by food intake and the fatty acid composition of the diet.
    Enser M; Roberts JL
    Biochem J; 1982 Sep; 206(3):561-70. PubMed ID: 6128973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stearoyl-CoA desaturase--a new player in skeletal muscle metabolism regulation.
    Dobrzyń A; Dobrzyń P
    J Physiol Pharmacol; 2006 Nov; 57 Suppl 10():31-42. PubMed ID: 17242489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.